Finding Relief After 30 Years of Migraine – Cathy’s story
Cathy has been living with migraine for over 30 years. A few weeks ago, I spoke with her about her long and difficult experience with migraine. She shared her story, hoping it would help others with migraine remain hopeful about finding pain relief. Dealing with…
A case demonstrating how a combination of Botox and erenumab can improve person’s quality of life: research from a Quebec team
Both Botox and CGRP antibodies can be effective for Chronic Migraine. Still, 50 to 50% of patients do not get this response for Botox or CGRP antibodies. What if a combination was used? A team from Quebec City reports on a 52 years-old woman suffering…
Combining Botox and a CGRP antibody: should it be covered by insurance companies?
It has come to the attention of Migraine Canada™ that many insurance companies are now refusing to cover the combination of Botox and a CGRP monoclonal antibody (BTX + CGRP MAB). Currently available CGRP monoclonal antibodies are erenumab (Aimovig) and galcanezumab (Emgality). Fremanezumab (Ajovy) is…
Ajovy (fremanezumab) approved by Health Canada
As of April 9th, Health Canada has approved Ajovy for use in Canada. This is great news for people living with migraine! ** ALWAYS discuss with your health care provider when making decisions about medications. What is Ajovy? Ajovy is a monoclonal antibody targeting CGRP….
Another new drug for migraine is likely on its way to Canada.
A completely new type of migraine preventive medication has been developed over the last ten years, one which uses antibodies to stop migraine attacks. These antibodies are similar to the ones that help you fight viruses, like the common cold, but they are made to…
CGRP monoclonal antibodies : summary and effectiveness
Dr Elizabeth Leroux, MD, FRCPC November 2022 Disclaimer: this information is based on published data but may not be applicable to your specific medical situation. This information does not replace a medical opinion provided in person after a full evaluation and examination. Discuss ALL medical…
CGRP Monoclonal Antibodies: access, and coverage
Disclaimer: This information is provided as a general overview of a complex topic. It can be hard to know which medicines you would have to pay for yourself. There might also be changes in Patient Support Programs (PSP) and this information may become outdated. For…
CGRP monoclonal antibodies (MABs): risks and side effects
Disclaimer: this information is based on published data but may not be applicable to your specific medical situation. This information does not replace a medical opinion performed in person after a full evaluation and examination. Discuss ALL medical decisions with your health care provider. As…
I have been told there is «nothing else to do»…now what?
Are there people with migraine who just don’t get better despite appropriate treatment? Every disease has severe forms. In every disease, there are people who do not respond to treatments. People with cancer still die if the treatments do not work. People with refractory migraine…
The cause of migraine: it’s all in your brain! The electrical and chemical sides of migraine
Migraine is not an imaginary problem. Migraine is a neurological disease. The next time someone tells you that migraine is «all in your head», do not hesitate to explain that migraine is a neurological disease with genetic components and with electrical and neurochemical mechanisms. Tell…
CGRP antibodies: practical details on access
We need better options for migraine prevention. And, thanks to the persistent researchers who worked so hard on CGRP, we now have a new class of medications, CGRP antibodies. Below is a table of the drugs with the doses, the brand names, and the…
